69.12USD-1.65%Mkt Cap: 13.54B USDP/E: —Last update: 2026-05-22
BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR sta…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap13.54B USD
Enterprise Value15.33B USD
Revenue (TTM)579.96M USD
Gross Profit481.11M USD
Net Income (TTM)-724.93M USD
Revenue/Share3.010 USD
Last Price69.12 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees834
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS10806X1028
Valuation
P/E (Trailing)—
P/E (Forward)187.41
PEG—
EV/EBITDA-30.72
EV/Revenue26.43
P/S23.73
P/B-6.56
EPS (TTM)-3.74
EPS (Forward)0.38
52W Range
31.7770% of range84.94
52W High84.94 USD
52W Low31.77 USD
Profitability
Gross Margin95.82%
Oper. Margin-54.47%
EBITDA Margin-86.02%
Profit Margin-144.39%
ROE34.74%
ROA-77.45%
Growth
Revenue Growth66.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-445.91M USD
CapEx (TTM)9.59M USD
FCF Margin-54.82%
FCF Yield-2.35%
Net Debt1.55B USD
Net Debt/EBITDA-3.11
Balance Sheet
Debt/Equity-0.89
Current Ratio1.52
Quick Ratio1.40
Book Value/Sh-10.7130 USD
Cash/Share4.800 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)101.89 USD
Target Range76.00 USD – 157.00 USD
# Analysts23
Ownership
Shares Out.195.86M
Float162.93M
Insiders3.92%
Institutions102.62%
Short Interest
Short Ratio9.8d
Short % Float13.69%
Short % Out.12.27%
Shares Short24.03M
Short (prev mo.)23.37M
Technical
SMA 5071.20 (-2.9%)
SMA 20065.85 (+5.0%)
Beta1.02
S&P 52W Chg28.31%
Avg Vol (30d)2.85M
Avg Vol (10d)3.03M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—